Refractory, advanced Breast cancer
Also known as: Refractory advanced Breast cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01590 | Everolimus | A mammalian target of rapamycin (mTOR) kinase inhibitor used to treat various types of malignancies. |
| DB00990 | Exemestane | An aromatase inhibitor used to treat breast cancer in postmenopausal women after treatment with tamoxifen. |
| DB01259 | Lapatinib | An antineoplastic agent and tyrosine kinase inhibitor used for the treatment of advanced or metastatic HER-positive breast cancer in patients who received prior chemotherapeutic treatments. |
| DB09073 | Palbociclib | An endocrine-based chemotherapeutic agent used in combination with other antineoplastic agents to treat HER2-negative and HR-positive advanced or metastatic breast cancer. |
| Drug | Drug Name | Phase | Status | Count |
|---|